Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
BTAIQ
$0.05
-6.25%
BTAIQ
· BioXcel Therapeutics, Inc.
$0.05
0.00 (-6.25%)
At close · Oct 7
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have identified conditions and events that raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$1.41M
Shares
31.31M
Volume · Oct 7
169.93K
Avg daily vol (3M)
6.01M
All webcasts
Earnings call · FY2024 Q2
BioXcel Therapeutics, Inc. (BTAIQ) Q2 2024 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$1.10M
+141.6% YoY
Diluted EPS
-$3.30
Net income
-$8.30M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 6, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 6, 2024 · complete as-filed document